Exagen Inc.

XGN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$55,641$52,548$45,563$48,299
% Growth5.9%15.3%-5.7%
Cost of Goods Sold$22,529$23,092$24,214$20,588
Gross Profit$33,112$29,456$21,349$27,711
% Margin59.5%56.1%46.9%57.4%
R&D Expenses$5,375$4,865$9,876$7,237
G&A Expenses$39,973$45,928$0$42,841
SG&A Expenses$41,373$47,428$52,018$44,541
Sales & Mktg Exp.$1,400$1,500$0$1,700
Other Operating Expenses$0$0$5,506$0
Operating Expenses$46,748$52,293$67,400$51,778
Operating Income-$13,636-$22,837-$46,051-$24,067
% Margin-24.5%-43.5%-101.1%-49.8%
Other Income/Exp. Net-$1,467-$819-$1,618-$2,609
Pre-Tax Income-$15,103-$23,656-$47,669-$26,676
Tax Expense$12$33-$282$175
Net Income-$15,115-$23,689-$47,387-$26,851
% Margin-27.2%-45.1%-104%-55.6%
EPS-0.83-1.34-2.77-1.68
% Growth38.1%51.6%-64.9%
EPS Diluted-0.83-1.34-2.77-1.68
Weighted Avg Shares Out18,20317,67917,08215,972
Weighted Avg Shares Out Dil18,20317,67917,08215,972
Supplemental Information
Interest Income$767$1,516$830$16
Interest Expense$2,234$2,335$2,448$2,625
Depreciation & Amortization$1,724$2,168$1,557$948
EBITDA-$11,145-$19,153-$43,664-$23,103
% Margin-20%-36.4%-95.8%-47.8%